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OBJECTIVE. It is important to recognize the imaging characteristics of peliosis hepatis
because peliotic lesions may mimic several different types of focal hepatic lesions
CONCLUSION. We illustrate the spectrum of imaging findings of peliosis hepatis, in-
cluding sonography, CT, MR, and angiography.
eliosis hepatis (also called he-
patic peliosis) is a rare benign
disorder causing sinusoidal dila-
tation and the presence of multi-
ple blood-filled lacunar spaces within the
liver [1]. “Peliosis” is a term derived from
the Greek pelios, which means “dusky” or
“purple,” referring to the color of the liver
parenchyma with peliosis. Similar blood-
filled spaces may be seen in the spleen,
lymph nodes, and other organs (including
the bone marrow, lungs, pleura, kidneys, ad-
renal glands, stomach, and ileum) [2]. The
size of the lesions may vary from 1 mm to
several centimeters.
Cause and Pathogenesis
The cause of peliosis hepatis can be related
to drugs (including anabolic steroids, oral
contraceptives, corticosteroids, tamoxifen,
diethylstilbestrol, azathioprine, 6-thiogua-
nine, 6-mercaptopurine, and methotrexate);
toxins (polyvinyl chloride, arsenic, and tho-
rium oxide); chronic wasting diseases (e.g.,
tuberculosis, leprosy, and various malignan-
cies, particularly hepatocellular carcinoma);
and infection in AIDS (so-called bacillary
peliosis caused by Bartonella henselae and
Bartonella quintana). In addition, several
other conditions are described as associated
with peliosis hepatis, including sprue, diabe-
tes mellitus, necrotizing vasculitis, and hema-
tologic disorders. Moreover, peliosis hepatis
may develop after renal or cardiac transplan-
tation. In 20–50% of patients, no associated
condition is identified.
The pathogenesis of peliosis remains
poorly understood, with various investiga-
tors proposing that the primary event could
be obstruction of hepatic outflow at the si-
nusoidal level, direct breakdown of sinusoi-
dal borders, dilatation of the central vein of
the hepatic lobule, or hepatocellular necro-
sis leading to cavity formation [1].
Pathology
The gross pathologic appearance of pelio-
sis hepatis is that of multiple, irregularly
shaped blood-filled hepatic cavities. The le-
sions typically involve the entire liver, but
focal peliosis hepatis has been described. At
microscopic examination, cystic dilated si-
nusoids filled with RBCs and bound by
cords of liver cells can be seen (Fig. 1).
Pathologists originally classified peliotic
lesions by the presence or absence of endo-
thelium [1]. However, although the blood-
filled cavities may have no endothelial lin-
ing, reendothelialization probably occurs
rapidly. Thus, the continuity/rupture of the
endothelial lining of the sinusoids is not a re-
liable criterion to define peliosis hepatis [2].
To distinguish peliosis hepatis from sinusoi-
dal dilatation, lesions should show evidence
of rupture of the reticulin fibers that support
the hepatocytes and sinusoids [1]. This rup-
ture may follow the intrinsic weakness of the
fibers of the endothelial wall (peliosis hepa-
tis of the phlebectatic type) or may be asso-
ciated with focal hepatocyte necrosis (pelio-
sis hepatis of the parenchymal type) [1].
Peliotic lesions in bacillary peliosis con-
tain clumps of organisms (i.e., B. henselae
or B. quintana) that stain with the Warthin-
Starry technique [1]. Patients with bacillary
peliosis often have peliosis of the spleen
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Clinical Presentation
Peliosis hepatis is often asymptomatic and
therefore is diagnosed incidentally at autopsy
[3]. In some instances, hepatomegaly, ascites,
portal hypertension, cholestasis, and hepatic
failure may be present. Severe abdominal
pain may result from rupture and intraperito-
neal hemorrhage. In the case of bacillary
peliosis, lymphadenopathy with B. henselae
and neurologic symptoms with B. quintana
are typical findings.
Peliosis hepatis can occur at any age. Al-
though a fetal form exists, peliosis hepatis usu-
ally develops in adults without regard to sex.
Natural History
The natural course of peliosis hepatis is re-
gression after drug withdrawal, cessation of
steroid therapy, or resolution of an associated
infectious disease. A pseudotumoral and
hemorrhagic evolution has also been de-
scribed [4, 5]. Complications associated with
A B
C D
Fig. 1—51-year-old woman with history of benign ovarian tumor and incidentally discovered hepatic mass.
A, Transverse unenhanced CT image shows hypoattenuating lesion (arrow) within segment VIII of liver.
B, On contrast-enhanced CT during hepatic arterial phase, lesion (arrow) shows marked homogeneous contrast enhancement.
C, On contrast-enhanced CT during portal venous phase, lesion (arrow) shows washout of contrast but is still hyperattenuating compared with liver parenchyma. Overall, 
lesion has vessel-like enhancement at CT.
D, At angiography, lesion (arrow) is clearly depicted.
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peliosis hepatis include liver failure, portal
hypertension, and liver rupture leading to he-
moperitoneum or shock. In general, if un-
treated, peliosis hepatis may be rapidly fatal.
Imaging Findings
The imaging findings of peliosis hepatis
are variable depending on the pathologic pat-
terns of disease, various stages of the blood




shows homogeneous hypoechoic lesions in
patients with hepatic steatosis, hyper-
echoic lesions in patients with a healthy
liver (Fig. 2), and heterogeneously hypo-
echoic lesions if complicated by hemor-
rhage. Doppler studies can show evidence
of both perinodular and intranodular vas-
cularity (Fig. 2).
Recently, the use of a sonographic contrast
agent (Levovist [Schering], a galactose and
palmitic acid compound) has been shown to
provide a “fast surge” central-echo enhance-
ment in peliotic lesions [6], a finding consis-
tent with the target sign described below.
CT Findings
On unenhanced CT, peliotic lesions usu-
ally appear as multiple areas of low attenu-
ation [3] (Fig. 3). CT findings vary with the
size of lesions, presence or absence of
thrombus within the cavities, and presence
of hemorrhage. In particular, peliotic le-
sions may be spontaneously hyperattenuat-
ing to liver parenchyma in certain patients
(probably related to intralesional hemor-
rhage). In addition, if peliotic cavities are
smaller than 1 cm in diameter, CT findings
may be normal [2]. Calcifications within
peliotic lesions have also been described.
On contrast-enhanced CT, peliotic le-
sions can be hypoattenuating to liver pa-
renchyma in the early acquisitions (Fig. 4)
and tend to become progressively isoatten-
uating with time. In addition, some lesions
can also show areas of increased attenua-
tion. Notably, larger cavities communicat-
ing with sinusoids display the same attenu-
E F
G
Fig. 1 (continued)—51-year-old woman with history of benign ovarian tumor and 
incidentally discovered hepatic mass.
E, On T2-weighted MR sequence, lesion (arrow) is faintly hyperintense compared 
with liver parenchyma.
F, On T1-weighted MR sequence, lesion (arrow) is hypointense compared with liver 
parenchyma.
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ation of blood vessels, whereas thrombosed
cavities have the same appearance as non-
enhancing nodules [2]. More often, during
the arterial phase of contrast enhancement,
peliotic lesions typically show early glob-
ular enhancement (vessel-like enhance-
ment) (Figs. 2 and 5) and multiple small
accumulations of contrast material in the
center of the lesions (the so-called target
sign) [3] (Fig. 3). During the portal venous
phase, a centrifugal progression of en-
hancement without a mass effect on
hepatic vessels is usually observed [3];
however, a centripetal progression of en-
hancement can also be seen [7] (Fig. 2). On
A B
C D
Fig. 2—42-year-old woman with peliosis hepatis.
A, Doppler sonographic study shows 4-cm diameter slightly heterogeneously hyperechoic lesion within healthy liver parenchyma. Notably, lesion has no mass effect on 
middle and right hepatic veins.
B, Transverse unenhanced CT image shows focal hypoattenuating lesion within right lobe of liver. Ascites is also evident.
C, In arterial phase of contrast enhancement, lesion shows marked peripheral ring enhancement. Lesion enhancement is isodense to aorta.
D, In portal venous phase, lesion enhancement is isodense to intrahepatic vessels. Note centripetal progression of contrast enhancement, which simulates hemangioma. 
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the delayed phase, late diffuse homoge-
neous hyperattenuation can also be seen in
the phlebectatic type of peliosis hepatis
(because of the lack of hemorrhagic paren-
chymal necrosis) [3]. This accumulation of
contrast material in the delayed phase can
be useful in the differential diagnosis with
other focal hepatic lesions that do not show
blood pooling. In some instances, small
(< 2 cm) peliotic lesions may also show hy-
perattenuation on both arterial and portal
venous phase images (Fig. 1).
MR Findings
The signal intensities of the lesions on
MR examination largely depend on the age
and status of the blood component. On T2-
weighted sequences, peliotic lesions are
usually hyperintense to liver parenchyma
A B
C D
Fig. 3—34-year-old man with AIDS and bacillary peliosis.
A, Transverse contrast-enhanced CT image shows large ill-defined, hypoattenuating lesion (white arrow) with heterogeneous peripheral enhancement within left liver lobe. 
Smaller subcapsular hypoattenuating lesion (black arrow) with ring enhancement can also be seen in right liver lobe.
B, Transverse contrast-enhanced CT image (different scan level) shows multiple enlarged lymph nodes, feature typically seen in bacillary peliosis.
C, Transverse contrast-enhanced CT image obtained after 9 months shows progression of disease with multiple hypoattenuating lesions disseminated within liver 
parenchyma with multiple small accumulations of contrast material in center of lesions (so-called target sign).
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Fig. 4—46-year-old 
woman with history of 
abdominal pain and 
peliosis hepatis. 
Transverse contrast-




disseminated within liver 
parenchyma. Multiple 
similar lesions can also 
be seen within spleen 
(arrows).
Fig. 5—34-year-old 
woman with AIDS and 
bacillary peliosis.
A, Transverse contrast-
enhanced CT image 
shows focal 
hyperattenuating lesion 
(arrow) within caudate 
lobe. Lesion has central 
hypoattenuation.
B, Transverse contrast-
enhanced CT image 
(different scan level) 
shows two additional 
focal hyperattenuating 
lesions within left lobe 
(large arrow) and right 
lobe (small arrow) of liver.
A
B
with multiple foci of high signal, likely at-
tributable to hemorrhagic necrosis [3, 4]
(Figs. 1, 6, and 7). On T1-weighted se-
quences, the lesions are hypointense be-
cause of the presence of subacute blood
(Figs. 1, 6, and 8), although isointense
(Fig. 7) and hyperintense foci are also de-
scribed in the literature [5]. On T1-
weighted images after contrast material
injection, peliotic lesions usually show en-
hancement (Figs. 6, 7, and 8). Similar to
CT, the enhancement is typically centrifu-
gal (from the center to the periphery of the
lesion); however, a recent report described
an unusual centripetal enhancement pat-
tern that may be confused with that of a he-
mangioma [7]. Cystic cavities may reveal
an enhancing rim that represents a he-
matoma. In addition, on fat-suppressed T1-
weighted images in the delayed phase after
administration of gadobenate dimeglu-
mine, strong contrast enhancement with a
branching appearance can also be observed
because of the vascular component of the
lesion [4] (Fig. 8).
Angiographic Findings
On angiography, peliotic lesions appear
as multiple vascular nodules (i.e., accumu-
lations of contrast material) during the late
arterial phase. The enhancement of peliotic
lesions typically is more distinct during the
parenchymal phase and persists during the
portal venous phase [8] (Fig. 1).
Differential Diagnosis
Hepatic Adenoma
Similar to peliosis, hepatic adenoma
might also be associated with the long-term
use of estrogens. In the case of diffuse peli-
osis hepatis, the differential diagnosis is rel-
atively easy. In addition, the presence of fat
in some adenomas is a useful sign to make a
differential diagnosis. In certain instances,
however, focal peliosis can be difficult to
differentiate from adenomas. In these pa-
tients, biopsy is often required to reach a de-
finitive diagnosis.
Hemangioma
The typical enhancement pattern of he-
mangiomas (i.e., peripheral ring or globular
enhancement with centripetal progression)
is opposite of peliosis hepatis, and therefore
differential diagnosis can be achieved in
most patients. In addition, hemangiomas
may be rather large lesions with a mass ef-

















































































Imaging of Peliosis Hepatis
AJR:187, July 2006 W49
A
Fig. 6—57-year-old man affected by non-Hodgkin’s lymphoma and peliosis hepatis 
caused by multiple chemotherapy treatments.
A, Transverse T2-weighted MR image faintly depicts multiple ill-defined lesions 
(arrowheads) with heterogeneous signal hyperintensity in both liver lobes.
B, Transverse T1-weighted MR image before contrast material injection faintly 
depicts multiple ill-defined, hypointense lesions (arrowheads) in both liver lobes.
C, On transverse T1-weighted MR image obtained after contrast material 
administration, lesions (arrowheads) show peripheral or complete contrast 
enhancement. Percutaneous biopsy (not shown) at two different sites showed 
peliosis hepatis. At follow-up after 1 year (not shown), lesions were still present but 
slightly smaller.
B C
lesions usually show no mass effect on he-
patic vessels.
Focal Nodular Hyperplasia
Focal nodular hyperplasias are typically
homogeneously hyperattenuating masses on
the arterial phase and isoattenuating on the
portal venous and delayed phases. These le-
sions often have a central scar with low at-
tenuation on the arterial and portal venous
phases and enhancement on the delayed
phase images. When such typical imaging
characteristics of focal nodular hyperplasia
are present, the differential diagnosis with
peliosis hepatis can be achieved easily.
Atypical forms of focal nodular hyperplasia
may not show the characteristic enhance-
ment patterns and the central scar just de-
scribed, however, and thus pose some prob-
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A
B
Fig. 7—33-year-old woman with peliosis hepatis and history of oral contraceptive use.
A, Transverse fat-suppressed T2-weighted image shows ill-defined, heterogeneously hyperintense lesion (arrow) 
within segment VI of liver.
B, On transverse fat-suppressed T1-weighted image before contrast material injection, lesion (arrow) is 
heterogeneously hypointense to liver parenchyma.
(Fig. 7 continues on next page)
Hepatic Abscess
The differential diagnosis between pelio-
sis hepatis and hepatic abscess is extremely
important to avoid the percutaneous drain-
age of peliotic lesions, which can be danger-
ous and even fatal [9]. With regard to imag-
ing criteria, a pyogenic abscess usually
presents as a mass with a multiseptated or
cluster-of-grapes appearance with nonen-
hancing contents.
Hypervascular Metastases
Although some hypervascular metastases
with fibrotic change can show mild hyperat-
tenuation in the delayed phase, hypervascu-
lar metastases are usually totally hypo- or
isoattenuating in the delayed phase of con-
trast enhancement because of the rapid
washout of contrast material. Thus, in gen-
eral, peliotic lesions are rarely confused
with hypervascular metastases.
Hepatocellular Carcinoma
Hepatocellular carcinoma is usually hy-
perattenuating in the arterial phase with
rapid washout in the portal venous phase
and iso- or hypoattenuation in the delayed
phase. Although rare, the possibility that
peliosis hepatis may mimic the presence of
hypervascular hepatocellular carcinoma has
been reported in the literature. In these pa-
tients, biopsy is often necessary to reach a
definitive diagnosis.
Treatment
The correct diagnosis of peliosis hepatis
is important because withdrawal of the of-
fending drug or toxin can resolve the disease
and prevent serious complications such as
hepatic failure or death related to intraab-
dominal hemorrhage. Because of its poten-
tial complications, surgical resection of the
involved liver parenchyma should always be
considered. In HIV-related peliosis hepatis
caused by B. henselae, clinical improve-
ment has been documented with the use of
antibiotics (i.e., erythromycin).
In conclusion, peliosis hepatis is a rare
clinical entity characterized by the presence
of multiple blood-filled lacunar spaces
within the liver. Awareness of the imaging
findings of this disorder is important to sug-
gest the diagnosis. Peliosis hepatis should
always be considered in the differential di-
agnosis of atypical focal hepatic lesions in
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C D
E
Fig. 7 (continued)—33-year-old woman with peliosis hepatis and history of oral 
contraceptive use.
C–E, After gadolinium injection, lesion (arrow) shows progressive enhancement from 
arterial (C) to portal venous (D) and delayed (E) phases, with “branching” 
appearance. Because of progressive fill-in of contrast enhancement, findings were 
initially thought to be consistent with hemangioma. Percutaneous biopsy of lesion 
(not shown) was consistent with hepatocellular adenoma. However, histologic 
examination performed on resected surgical specimen showed peliosis hepatis. 
Centripetal enhancement in peliotic lesions is rather uncommon finding; branching 
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A B
C
Fig. 8—45-year-old woman with right upper quadrant pain, history of oral 
contraceptive use, and peliosis hepatis.
A, Transverse fat-suppressed T2-weighted MR image shows ill-defined mass with 
heterogeneous signal hyperintensity in right liver lobe. Lesion with same 
characteristics is also evident within left liver lobe.
B, Transverse fat-suppressed T1-weighted MR image before contrast material 
injection does not show any significant abnormality of liver parenchyma.
C, After contrast material administration, transverse fat-suppressed T1-weighted 
MR image shows heterogeneous contrast enhancement of lesions seen on T2-
weighted sequence.
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